Pharmacoeconomics and cost-effectiveness of treatments related to breast and cervix cancers

Breast and cervix cancers are major diseases among women with increasing incidence worldwide. Apart from disease burden, costs related to treatments and diagnoses of breast and cervical cancers put a major stress on the health and economic status of patients as well as the countries they are from. In most low- and middle-income countries, treatments of these diseases cause a larger economic burden on patients. The introduction of pharmacoeconomics reduces the economic burden of disease management on both patient and governments. This chapter discusses the worldwide cost burden and cost-effective treatments of breast and cervix cancer, which may be a pharmacoeconomic input.